Clinical Trials Logo
  1. Home
  2. Oligohydramnios
  3. NCT03277417
  4. Details
NCT03277417 Clinical Trial

Does Amniotic Fluid Index Affect the Fetal Cardiac Performance?

Oligohydramnios Clinical Trial

Official title:
Does the Amniotic Fluid Index Affect the Fetal Cardiac Performance?

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT03277417
Other study ID # HYMC-0037-17
Secondary ID
Status Not yet recruiting
Phase N/A
First received August 30, 2017
Last updated September 6, 2017
Start date September 2017
Est. completion date September 2019

Study information
Verified date September 2017
Source Hillel Yaffe Medical Center
Contact Rinat Gabbay-Benziv, MD
Phone 972-4-6304512
Email rinatg@hy.health.gov.il
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To evaluate and compare fetal cardiac performance by fetal echocardiography and delivery outcome between fetuses with isolated oligohydramnios, normal amniotic fluid and polyhydramnios.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 90
Est. completion date September 2019
Est. primary completion date September 2019
Accepts healthy volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Gestational age 24-42 weeks

- Singleton pregnancies

Exclusion Criteria:

- Fetal anatomical or chromosomal abnormality

- Known fetal cardiac defect

- Suspected fetal infection

- Suspected IUGR

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Echocardiography
Imaging of fetal heart and amniotic fluid

Locations
Country Name City State
Israel Hillel Yaffe Medical Center H_adera

Sponsors (1)
Lead Sponsor Collaborator
Hillel Yaffe Medical Center

Country where clinical trial is conducted

Israel, 

Outcome
Type Measure Description Time frame Safety issue
Primary Fetal cardiac ventricles The width of the fetal cardiac ventricles will be measured and compared between all three groups One month
Secondary Gestational age Gestational age at delivery will be compared between the three groups One month
Secondary Mode of delivery Mode of delivery will be compared between the three groups One month
Secondary Birth weight Birth weight will be compared between the three groups One month
See also
  Status Clinical Trial Phase
Recruiting NCT00787163 - Amnioinfusion Initiative Phase 3
Completed NCT05059093 - Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
Not yet recruiting NCT05043753 - "Fetal gRowth AbnorMality dEtection Trial" N/A
Recruiting NCT02997345 - PPROM Registry (Preterm Premature Rupture of Membranes)
Completed NCT03935607 - The Added Contribution of Transvaginal Sonographic Evaluation of Amniotic Fluid Index
Completed NCT02581774 - Active Induction of Labor in Pregnancies Complicated With Oligohydramnios at Term Phase 4
Terminated NCT01569035 - Warfarine in Unexplained Oligohydramnios Phase 4
Completed NCT01140971 - Foley Catheter Versus Vaginal Misoprostol for Cervical Ripening and Induction of Labor N/A
Recruiting NCT04684680 - The Role of Zamzam Water in Idiopathic Oligohydramnios N/A
Not yet recruiting NCT03815968 - Low Sodium Diet in Oligohydramnios Assigned for Conservative Management N/A
Enrolling by invitation NCT04451109 - Dilapan-S®: A Multicenter US E-registry
Recruiting NCT02901340 - Fetal Renal Artery Doppler Indices in Borderline Isolated Oligohydramnios N/A
Terminated NCT01682928 - Hydrotherapy for the Reversal of Oligohydramnios N/A
Not yet recruiting NCT05474326 - Effect of Intermittent Pneumatic Compression Device of Lower Limbs in Oligohydramnios N/A
Completed NCT05332015 - The Effect of Oral Hypotonic Hydration in Isolated Oligohydramnios N/A